News


ORTHOCON® Announces Uninterrupted Availability of HEMASORB Resorbable Hemostatic
Bone Putty

August 23, 2012 - Click to Download

ORTHOCON® Names David J. Hart Vice President of Business Operations
March 15, 2012 - Click to Download

Canaan Partners Closes $600 Million Fund, Canaan IX
January 9, 2012 - Click to Read More

ORTHOCON® Receives CE Mark and Health Canada Medical Device License for HEMASORB®
April 21, 2011 - Click to Download

ORTHOCON® Announces U.S. Market Launch of HEMASORB®
February 17, 2011 - Click to Download

ORTHOCON® Names John J. Pacifico President and Chief Executive Officer
January 10, 2011- Click to Download






ORTHOCON® estimates that over 3.5 million patients undergoing surgeries in the United States and Europe each year could benefit from the intraoperative use of HEMASORB.


ORTHOCON® Announces Uninterrupted Availability of HEMASORB Resorbable Hemostatic Bone Putty
August 23, 2012 - Click to Download